BVF II GP LLC

Director at CTI BIOPHARMA CORP · on record since Jun 28, 2023
See Explanation of Responses at PALVELLA THERAPEUTICS, INC. · on record since May 22, 2023
Director at Olema Pharmaceuticals, Inc. · on record since Jun 21, 2023
See explanation of responses at Structure Therapeutics Inc. · on record since Feb 13, 2023
10% owner at Repare Therapeutics Inc. · on record since Nov 17, 2023
See Explanation of Responses at enGene Therapeutics Inc. · on record since Nov 13, 2023
See Explanation of Responses at POINT Biopharma Global Inc. · on record since Nov 6, 2023
Director at Rain Oncology Inc. · on record since Jan 29, 2024
See Remarks; Former 10% Owner at Rain Oncology Inc. · on record since Apr 27, 2021
See Explanation of Responses at Allakos Inc. · on record since Jan 26, 2024
Director at IMMUNIC, INC. · on record since Feb 27, 2026
See Explanation of Responses at IMMUNIC, INC. · on record since Feb 27, 2026
Director at MoonLake Immunotherapeutics · on record since Apr 2, 2026
10% owner at MoonLake Immunotherapeutics · on record since Apr 2, 2026
10% owner at XOMA Royalty Corp · on record since May 18, 2026
See Explanation of Responses at MoonLake Immunotherapeutics · on record since Jun 22, 2026
See Explanation of Responses at CTI BIOPHARMA CORP · on record since Mar 4, 2020
See Explanation of Responses at IDEAYA Biosciences, Inc. · on record since Jun 22, 2020
See Explanation of Responses at · on record since May 18, 2020
See Explanation of Responses at · on record since Jun 10, 2020
See Explanation of Responses at · on record since Aug 20, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 6, 2020
See Explanation of Responses at · on record since Jan 26, 2021
See Explanation of Responses at · on record since Nov 8, 2021
See Explanation of Responses at · on record since Jan 10, 2022
See Explanation of Responses at · on record since Feb 7, 2022
See Explanation of Responses at · on record since Jun 27, 2022
Director at · on record since May 20, 2022
See Explanation of Responses at · on record since Jul 21, 2022
See Explanation of Responses at · on record since Dec 22, 2022
Director at · on record since Jan 13, 2023
See Remarks and Footnotes at · on record since Aug 25, 2020
10% owner at · on record since Oct 5, 2026

Insider trading activity of BVF II GP LLC

Transactions on record: 53; since Aug 20, 2020

Open-market buys: 42; $50M

Open-market sells: 0

Companies traded: 9; last filing Jun 18, 2024

Figures computed from official regulatory filings — .

Companies where BVF II GP LLC has traded

1 tx · Jun 18, 2024
6 tx · $5.3M · Nov 6, 2023
8 tx · $3M · Jan 19, 2023
3 tx · $10M · Nov 10, 2022
9 tx · $21.9M · Jun 6, 2022
12 tx · $931.8K · May 21, 2021
6 tx · $20M · Apr 5, 2021
2 tx · $1.8M · Mar 24, 2021
6 tx · $2.2M · Nov 6, 2020

Track record of BVF II GP LLC

Statistical track record

Free account

Open-market buys: 45

Last buy: Nov 3, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BVF II GP LLC

Co-insiders of BVF II GP LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Olema Pharmaceuticals, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	23,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	57,618	11.64 USD	$670.7K	conv 34	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	83,708	14.07 USD	$1.2M	conv 28	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	10,106	14.07 USD	$142.2K	conv 28	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	103,885	14.07 USD	$1.5M	conv 28	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	132,016	11.64 USD	$1.5M	conv 35	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	26,772	11.64 USD	$311.6K	conv 36	SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	OtherD (derivative)	350,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	Other	-3,500,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	OtherD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	Other	-300,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	Other	-2,600,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	OtherD (derivative)	260,000	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Nov 10, 2022	Buy	685,330	5.83 USD	$4M	conv 47Cluster	SEC
Rain Oncology Inc.Listing unverified	Nov 10, 2022	Buy	54,857	5.83 USD	$319.8K	conv 34Cluster	SEC
Rain Oncology Inc.Listing unverified	Nov 10, 2022	Buy	970,171	5.83 USD	$5.7M	conv 53Cluster	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	353,344	12.29 USD	$4.3M	conv 17	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	3,809	13.21 USD	$50.3K	conv 5	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	31,903	12.29 USD	$392.1K	conv 8	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	258,797	12.29 USD	$3.2M	conv 13	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	20	13.21 USD	$264.2	conv 5	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	464,235	11.68 USD	$5.4M	conv 33	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	61,156	11.68 USD	$714.3K	conv 15	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	3,040	13.21 USD	$40.2K	conv 5	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	660,654	11.68 USD	$7.7M	conv 44Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Olema Pharmaceuticals, Inc.Listing on record	Jun 18, 2024	AwardD (derivative)	23,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	57,618	11.64 USD	$670.7K	conv 34	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	83,708	14.07 USD	$1.2M	conv 28	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	10,106	14.07 USD	$142.2K	conv 28	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	103,885	14.07 USD	$1.5M	conv 28	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	132,016	11.64 USD	$1.5M	conv 35	SEC
Kymera Therapeutics, Inc.Listing on record	Nov 6, 2023	Buy	26,772	11.64 USD	$311.6K	conv 36	SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	OtherD (derivative)	350,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	Other	-3,500,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	OtherD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	Other	-300,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	Other	-2,600,000	—	n/a (No price was disclosed in the filing)		SEC
Cullinan Therapeutics, Inc.Listing on record	Jan 19, 2023	OtherD (derivative)	260,000	—	n/a (No price was disclosed in the filing)		SEC
Rain Oncology Inc.Listing unverified	Nov 10, 2022	Buy	685,330	5.83 USD	$4M	conv 47Cluster	SEC
Rain Oncology Inc.Listing unverified	Nov 10, 2022	Buy	54,857	5.83 USD	$319.8K	conv 34Cluster	SEC
Rain Oncology Inc.Listing unverified	Nov 10, 2022	Buy	970,171	5.83 USD	$5.7M	conv 53Cluster	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	353,344	12.29 USD	$4.3M	conv 17	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	3,809	13.21 USD	$50.3K	conv 5	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	31,903	12.29 USD	$392.1K	conv 8	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	258,797	12.29 USD	$3.2M	conv 13	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	20	13.21 USD	$264.2	conv 5	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	464,235	11.68 USD	$5.4M	conv 33	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	61,156	11.68 USD	$714.3K	conv 15	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	3,040	13.21 USD	$40.2K	conv 5	SEC
Repare Therapeutics Inc.Listing unverified	Jun 6, 2022	Buy	660,654	11.68 USD	$7.7M	conv 44Unusual size	SEC